Epsilon Healthcare Ltd (ASX:EPN) Share Price

Company Profile

Business description
Epsilon Healthcare Ltd is a diversified healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, (the Southport Facility) in Southport, Australia and the Tetra Health clinic group. It is engaged in two segments: Contract Development and Manufacturing activities; and Telehealth medical practice services. Contract Development and Manufacturing activities as a CDMO for Australian domiciled and international clients in the area of Active Pharmaceutical Ingredient (API) manufacture and finished formulation production. Key revenue is generated from Contract Development and Manufacturing.
Contact
1 Jamison Street
Level 1
SydneyNSW2000
AUS
T: +61 288393000
https://www.epsilonhealthcare.com.au
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees

Recommended

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,138.50	11.40	0.12%
CAC 40	8,358.76	3.33	-0.04%
DAX 40	25,405.34	143.70	0.57%
Dow JONES (US)	49,590.20	86.13	0.17%
FTSE 100	10,140.70	16.10	0.16%
HKSE	26,744.55	136.07	0.51%
NASDAQ	23,733.90	62.56	0.26%
Nikkei 225	53,549.16	1,609.27	3.10%
NZX 50 Index	13,656.05	27.24	-0.20%
S&P 500	6,977.27	10.99	0.16%
S&P/ASX 200	8,808.50	17.20	0.20%
SSE Composite Index	4,133.00	32.28	-0.78%